Forefront Analytics’s LeonaBio Inc LONA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,660
Closed -$123K 68
2024
Q2
$123K Buy
4,660
+2,598
+126% +$61.3K 0.06% 62
2024
Q1
$56.5K Sell
2,062
-915
-31% -$29K 0.03% 66
2023
Q4
$72.3K Buy
2,977
+896
+43% +$15.9K 0.04% 63
2023
Q3
$42K Hold
2,081
0.02% 67
2023
Q2
$61.4K Sell
2,081
-82
-4% -$2.34K 0.04% 62
2023
Q1
$54.1K Sell
2,163
-72
-3% -$2.32K 0.03% 72
2022
Q4
$70.9K Buy
+2,235
New +$70.4K 0.04% 63

Other funds holding LONA

Forefront Analytics's LONA Position: Q3 2024 in Review

Forefront Analytics sold out of LeonaBio Inc (LONA) in Q3 2024, closing a stake of 4,660 shares — an estimated $123K sold.

Forefront Analytics first reported a position in LONA in Q4 2022 and held it in 7 quarters. The position peaked at $123K in Q2 2024. 58 funds tracked by Wall St. Rank hold LONA as of Q3 2024.

  • Forefront Analytics reported no remaining LeonaBio Inc position as of Q3 2024 after selling out during the quarter.
  • Forefront Analytics sold 4,660 LeonaBio Inc shares in Q3 2024, an estimated $123K.
  • Forefront Analytics first reported a position in LeonaBio Inc in Q4 2022 and held it in 7 quarters.
  • Forefront Analytics's LeonaBio Inc position peaked at $123K in Q2 2024.
  • 58 funds tracked by Wall St. Rank held LeonaBio Inc as of Q3 2024.

Based on Forefront Analytics's 13F filing for Q3 2024, filed 14 Nov 2024.